[Trial of delayed-action neuroleptics in the treatment of acute psychotic conditions].
D000208:Acute Disease; D000328:Adult; D003692:Delayed-Action Preparations; D004361:Drug Tolerance; D005260:Female; D005476:Fluphenazine / Q000627:therapeutic use; D006212:Hallucinations / Q000188:drug therapy; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D010259:Paranoid Disorders / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy; D012562:Schizophrenia, Disorganized / Q000188:drug therapy; D013843:Thiazines / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000008:administration & dosage* / Q000009:adverse effects
D003692:Delayed-Action Preparations; D010879:Piperazines; D013843:Thiazines; D014149:Tranquilizing Agents; D005476:Fluphenazine
Essai d'application des neuroleptiques à effet prolongé au traitement des états psychotiques aigus.